Search peptides, terms, sources/
Research source · 2026

Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy, A meta-analysis of randomized controlled trials

About this source

Kind
Research
Design
Meta-analysis, RCT
Population
Human, HIV-associated lipodystrophy, pooled across 5 RCTs
Sample size
5 RCTs pooled
Primary or secondary
secondary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 August 2026

Limitations

Results apply to people with HIV-associated lipodystrophy only.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.